DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study Evaluating BLI-489 and Piperacillin in Healthy Subjects

Information source: Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy Subjects

Intervention: BLI-489/Piperacillin (Drug); BLI-489 (Drug); Piperacillin (Drug)

Phase: Phase 1

Status: Completed

Sponsored by: Wyeth is now a wholly owned subsidiary of Pfizer

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth is now a wholly owned subsidiary of Pfizer


The purpose of this study is to evaluate how BLI-489 and piperacillin interact when given together to healthy subjects.

Clinical Details

Official title: A Randomized, Open-label, Single-dose, 3-period Crossover Study to Describe the Pharmacokinetic Parameters of BLI-489 and Piperacillin When Administered Simultaneously Compared to When Each is Administered Alone.

Study design: Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Pharmacokinetics as evaluated by drug concentrations in the blood and urine.

Secondary outcome: Safety as measured by the number of adverse events and serious adverse events.


Minimum age: 18 Years. Maximum age: 50 Years. Gender(s): Both.


Inclusion Criteria: 1. Men or women of non-childbearing potential, aged 18 to 50 years of age inclusive at screening. 2. Body mass index (BMI) in the range of 18 to 32 kg/m2 and body weight greater than or equal to 50 kg. 3. Healthy as determined by the investigator on the basis of the screening evaluations. 4. Nonsmoker of smoker of fewer than 10 cigarettes per day as determined by history. Exclusion Criteria: 1. Presence of history of any disorder that may prevent the successful completion of the study. 2. History of drug abuse within 1 year.

Locations and Contacts

Philadelphia, Pennsylvania 19148, United States
Additional Information

Starting date: May 2009
Last updated: July 16, 2009

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017